MRNA

Moderna, Inc.

196.76 USD

Last updated Oct 9, 04:32 UTC

Yesterday HIGH

$197.69

Yesterday LOW

$182.51

52w HIGH

$212.19

52w LOW

$22.29

EPS

-1.97

PE

-99.88

Next Earnings

Nov 5, 2026

Overview News Unusual Options Flow Insider Transactions Government Trades Fundamentals

Moderna, Inc. stock is up 45.09% since 30 days ago. The next earnings date is Nov 5, 2026. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 7 October’s closed higher than September. In the last 10 Unusual Options Trades, there were 5 PUTs, 5 CALLs. 0% of analysts rate it a buy.

Options Flow Last 10
Date & Time	Expiration Date	Strike Price	Trade Type	Size	Open Interest

08 Oct 19:30	09 Oct, 2026	185.00	PUT	288	1527
08 Oct 19:38	19 Mar, 2027	180.00	CALL	10	464
08 Oct 19:44	09 Oct, 2026	200.00	CALL	260	2941
08 Oct 19:44	09 Oct, 2026	200.00	CALL	250	2941
08 Oct 19:48	18 Dec, 2026	70.00	CALL	2	898
08 Oct 19:48	20 Nov, 2026	200.00	CALL	10	8190
08 Oct 19:50	09 Oct, 2026	187.50	PUT	376	856
08 Oct 19:50	09 Oct, 2026	192.50	PUT	188	336
08 Oct 19:54	16 Oct, 2026	190.00	PUT	46	888
08 Oct 19:58	16 Oct, 2026	190.00	PUT	45	888

Advanced Data Unlock

Evette Mitkov

Tue Sep 29, 2026

Moderna Sets Another Fresh 52-Week High: What's Happening?

Moderna shares are climbing again Tuesday, touching a new 52-week high of $208.90 on continued momentum from strong clinical trial news.
Piero Cingari

Fri Sep 25, 2026

AMD Hits $1 Trillion, Muse Spooks Subscription Stocks: This Week on Wall Street

AMD crossed $1 trillion and Meta's Muse rattled subscription stocks. Meanwhile, Treasury yields hit 2007 highs.
Evette Mitkov

Fri Sep 25, 2026

Moderna Stock Reached New 52-Week High: What's Happening?

Moderna Inc. (NASDAQ: MRNA) shares are trading higher Friday, hitting a fresh 52-week high on anticipation of clinical trial data.
Mohd Haider

Fri Sep 25, 2026

Why is Moderna (MRNA) Stock Trending After Hours?

Moderna shares rose 0.09% after hours Thursday as investors eyed upcoming oncology data at a major European conference.
Benzinga Insights

Wed Sep 23, 2026

10 Health Care Stocks Whale Activity In Today’s Session

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner. Traders often
Avi Kapoor

Wed Sep 23, 2026

TriSalus Life Sciences, Lakefront Biotherapeutics, Editas Medicine And Other Big Stocks Moving Higher On Wednesday

U.S. stocks fell as Nasdaq dropped 100+ points, while TriSalus surged 5.8% on FDA clearance; Securitize, Lakefront and others also gained.
Avi Kapoor

Tue Sep 22, 2026

Top 3 Health Care Stocks That May Keep You Up At Night This Month

Thermo Fisher, Moderna and Agilent show overbought RSI readings above 70, warning momentum-focused investors of potential near-term weakness.
Benzinga Newsdesk

Mon Sep 21, 2026

Moderna shares are trading higher. The company announced three abstracts on its mRNA-based individualized neoantigen therapy intismeran autogene have been accepted for presentation at the ESMO Congress 2026.
Benzinga Insights

Mon Sep 21, 2026

10 Health Care Stocks Whale Activity In Today’s Session

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner. Traders often
Evette Mitkov

Mon Sep 21, 2026

Moderna Stock Is Soaring: What's Going On?

Moderna shares are surging Monday. The company announced three intismeran autogene abstracts were accepted for presentation at ESMO Congress.

Citigroup

Wed Sep 30, 12:21

sell

downgrade

Advanced Data Unlock

James Mock, Chief Financial Officer

Mon Oct 5, 2026

MRNA Recent Insider Trades and Stock Chart

1,454 shares converted
Stephen Hoge, President

Tue Sep 15, 2026

MRNA Recent Insider Trades and Stock Chart

40,281 shares sold
Stephen Hoge, President

Mon Sep 14, 2026

MRNA Recent Insider Trades and Stock Chart

40,294 shares sold
James Mock, Chief Financial Officer

Thu Sep 10, 2026

MRNA Recent Insider Trades and Stock Chart

34,836 shares sold
James Mock, Chief Financial Officer

Fri Sep 4, 2026

MRNA Recent Insider Trades and Stock Chart

11,797 shares converted
Thyme Shannon Klinger, Chief Legal Officer

Fri Sep 4, 2026

MRNA Recent Insider Trades and Stock Chart

11,797 shares converted